Nanobac Pharmaceuticals Announces Sharpened Focus
TAMPA, Fla.--(BUSINESS WIRE)--March 31, 2006--Nanobac Pharmaceuticals, Inc. (OTCBB:NNBP) ("Nanobac" or "the Company") today announced a sharpened focus on developing safe and effective drug therapies for diseases where calcification, or "calcium deposits", is a dominant feature.